相关实验视频

Updated: May 16, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

解码转移性乳腺癌临床试验:最佳治疗顺序的实用见解

Chiara Corti^1,2,3,4,5, Hope S Rugo^6,7, Sara M Tolaney^1,2,3

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

|May 14, 2025

概括

对转移性乳腺癌 (MBC) 进行疗法测序需要整合临床数据和患者因素. 本综述指导了ER+,ER和HER2+MBC的最佳治疗顺序,解决了耐药性和ADC等新药.

科学领域:

在瘤学瘤学.
临床治疗学临床治疗学
翻译医学是一种翻译医学.

背景情况:

转移性乳腺癌 (MBC) 的管理涉及复杂的疗法序列.
治疗选择的快速进步需要更新的策略来优化患者的治疗结果.
了解耐药机制和评估新型药物对于个性化护理至关重要.

研究的目的:

提供对MBC管理的序列化策略的全面审查.
讨论对CDK4/6抑制剂的耐药性在ER+疾病中的影响.
评估抗体-药物合物 (ADC) 在ER+和ER-MBC中的作用.
探索对HER2阳性MBC的治疗方法,包括大脑转移.

主要方法:

临床试验数据和现实世界的证据的批判性评估.
对新出现的抗药性模式和治疗疗效的分析.
审查研究新药和治疗序列的关键试验.
考虑患者特异性因素和生物标志物指导.

主要成果:

对CDK4/6抑制剂的新兴耐药性需要对ER+MBC的后续疗法进行重新评估.
在ER+和ER-MBC中,ADC显示出前景,尽管存在试验设计挑战.
对HER2+MBC的第一线和维护策略是由里程碑式的试验提供信息.
大脑转移显著影响HER2+疾病的测序决策.

结论:

在MBC中优化治疗序列需要整合多种数据源.
基于证据的策略和对新药的仔细考虑是必不可少的.
解决耐药性和根据生物标志物定制疗法可以改善患者的治疗结果.
个性化治疗计划是最大化益处和最大限度地减少MBC中毒性的关键.

更多相关视频

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...